Clinical trials recruiting for Thromboembolism
3
Recruiting trials
0
US states with sites
3
Countries
33%
Accept healthy volunteers
Phase breakdown
Phase 4 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Apixaban 2.5 mg BID | 1 |
| Infliximab Adalimumab y Golimumab | 1 |
| Standard-dose DOAC | 1 |
| Tofacitinib | 1 |
Self-screener
Recruiting trials
- CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
Related conditions
Trials recruiting for Thromboembolism often also study these conditions. Each links to its own recruiting-trial list.
Atrial fibrillation 535Ulcerative colitis 288Left Atrial Appendage Closure 5Hemorrhage 3Cardiovascular Diseases 164
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Thromboembolism trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.